Inspire Medical Systems, Inc. Cost of Revenue
Inspire Medical Systems, Inc. (INSP) reported Cost of Revenue of $13.64 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2020-02-25
- Inspire Medical Systems, Inc. cost of revenue for the quarter ending 2018-12-31 was $3.19M, a 69.75% increase year-over-year.
- Inspire Medical Systems, Inc. cost of revenue for the quarter ending 2018-09-30 was $2.47M, a 57.64% increase year-over-year.
- Inspire Medical Systems, Inc. cost of revenue for the quarter ending 2018-06-30 was $2.10M, a 52.76% increase year-over-year.
- Inspire Medical Systems, Inc. cost of revenue for the quarter ending 2018-03-31 was $2.29M, a 91.81% increase year-over-year.
- Inspire Medical Systems, Inc. cost of revenue for fiscal 2019 was $13.64M, a 35.67% increase from fiscal 2018.
- Inspire Medical Systems, Inc. cost of revenue for fiscal 2018 was $10.06M, a 67.10% increase from fiscal 2017.
- Inspire Medical Systems, Inc. cost of revenue for fiscal 2017 was $6.02M, a 54.11% increase from fiscal 2016.
- Inspire Medical Systems, Inc. cost of revenue for fiscal 2016 was $3.90M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2019-12-31 | $13.64M 10-K · filed 2020-02-25 | |||
| 2018-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $5.66M derived: sum of 2 quarters · filed 2020-02-25 | $7.76M derived: sum of 3 quarters · filed 2020-02-25 | $10.06M 10-K · filed 2020-02-25 |
| 2018-09-30 | $2.47M 10-Q · filed 2018-11-06 | $4.57M derived: sum of 2 quarters · filed 2018-11-06 | $6.86M 10-Q · filed 2018-11-06 | $8.74M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $2.10M 10-Q · filed 2018-08-07 | $4.40M 10-Q · filed 2018-08-07 | $6.28M derived: sum of 3 quarters · filed 2020-02-25 | $7.84M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $2.29M 10-Q · filed 2018-06-07 | $4.17M derived: sum of 2 quarters · filed 2020-02-25 | $5.74M derived: sum of 3 quarters · filed 2020-02-25 | $7.12M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.45M derived: sum of 2 quarters · filed 2020-02-25 | $4.82M derived: sum of 3 quarters · filed 2020-02-25 | $6.02M 10-K · filed 2020-02-25 |
| 2017-09-30 | $1.56M 10-Q · filed 2018-11-06 | $2.94M derived: sum of 2 quarters · filed 2018-11-06 | $4.14M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $1.38M 10-Q · filed 2018-08-07 | $2.57M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $1.20M 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | $3.90M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |